Vista Wealth Management Group, LLC Lyell Immunopharma, Inc. Transaction History
Vista Wealth Management Group, LLC
- $1.49 Billion
- Q4 2024
A detailed history of Vista Wealth Management Group, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Vista Wealth Management Group, LLC holds 13,043 shares of LYEL stock, worth $7,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,043
Previous 20,869
37.5%
Holding current value
$7,173
Previous $28,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LYEL
# of Institutions
114Shares Held
142MCall Options Held
18.1KPut Options Held
200-
Mwg Management Ltd. Washington, DC20.2MShares$11.1 Million30.81% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$8.3 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$8.3 Million13.96% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$7.42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.77MShares$5.37 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $136M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...